Figure 3
From: TGM3, a candidate tumor suppressor gene, contributes to human head and neck cancer
Correlation between TGM3 expression and clinicopathological parameters and clinical outcome in patients with HNSCCs. (A) Representative images show immunohistochemical staining for TGM3 expression in normal epithelial tissue, well differentiated HNSCC, moderately differentiated HNSCC and poorly differentiated HNSCC. (B) The associations between TGM3 expression and clinicopathological factors were investigated in patients with HNSCCs (Twelve patients were excluded due to the samples shedding in the process of antigen retrieval and due to an insufficient number of tumor cells in the sections). (C) Kaplan-Meier survival curves illustrate the overall survival of patients with HNSCC relative to TGM3 expression (Two patients were excluded from survival analysis because of missing follow-up data).